Effects of 4-week Sitagliptin or Exenatide Therapy on Endothelial Progenitor Cells in Type 2 Diabetic Patients. A Non-controlled Open-label Pilot Trial.
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2010
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.